Cardiovascular and renal effects of calcitonin gene-related peptide in hypertensive dogs

Kenneth M. Verburg, Ronald H. Freeman, Daniel Villarreal, Michael W. Brands

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The systemic cardiovascular and renal effects of synthetic β-human calcitonin gene-related peptide (β-hCGRP) were examined in conscious normotensive and one-kidney one-clip (1K-1C) hypertensive dogs. β-hCGRP was infused intravenously at 10 and 50 ng/kg/min for 75-min periods each. Mean arterial pressure did not change significantly (p>0.05) in either group during low dose infusion of β-hCGRP, but infusion of β-hCGRP at 50 ng/kg/min produced a fall in mean arterial pressure from 140±4 to 116±6 mmHg (p<0.05) in the hypertensive dogs (n=4) and from 100±4 to 78±3 mmHg (p<0.05) in the normotensive dogs (n=4). Heart rates increased significantly during infusion of β-hCGRP in both groups. Also, renal sodium and potassium excretion decreased (p<0.05) in the two groups at both the low and high doses of β-hCGRP. Creatinine clearance was unchanged in normal dogs and decreased (p<0.05) in 1K-1C hypertensive dogs at the high rate of β-hCGRP infusion. The clearance of p-aminohippurate increased approximately 20% (p<0.05) in both groups with the low dose infusion of β-hCGRP but further increases were elecited only in the normotensive dogs in response to the elevation in the β-hCGRP infusion rate. Plasma renin and aldosterone levels increased (p<0.05) above control levels during the maximum hypotensive response to β-hCGRP infusion in both groups. These data indicate that β-hCGRP is a potent blood pressure lowering agent with important effects on renal hemodynamics and excretory function in both normotensive and 1K-1C hypertensive dogs during sustained intravenous infusions.

Original languageEnglish (US)
Pages (from-to)663-669
Number of pages7
JournalPeptides
Volume10
Issue number3
DOIs
StatePublished - Jan 1 1989
Externally publishedYes

Fingerprint

p-Aminohippuric Acid
Calcitonin Gene-Related Peptide
Level control
Blood pressure
Hemodynamics
Aldosterone
Renin
Creatinine
Potassium
Sodium
Dogs
Kidney
Plasmas
Arterial Pressure
Surgical Instruments
Intravenous Infusions
Heart Rate
Blood Pressure

Keywords

  • Calcitonin gene-related peptide
  • Mean arterial pressure
  • Renal sodium excretion
  • Renovascular hypertension

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Endocrinology
  • Cellular and Molecular Neuroscience

Cite this

Cardiovascular and renal effects of calcitonin gene-related peptide in hypertensive dogs. / Verburg, Kenneth M.; Freeman, Ronald H.; Villarreal, Daniel; Brands, Michael W.

In: Peptides, Vol. 10, No. 3, 01.01.1989, p. 663-669.

Research output: Contribution to journalArticle

Verburg, Kenneth M. ; Freeman, Ronald H. ; Villarreal, Daniel ; Brands, Michael W. / Cardiovascular and renal effects of calcitonin gene-related peptide in hypertensive dogs. In: Peptides. 1989 ; Vol. 10, No. 3. pp. 663-669.
@article{aa7d8817dc5c47398d2f94b0a85279f0,
title = "Cardiovascular and renal effects of calcitonin gene-related peptide in hypertensive dogs",
abstract = "The systemic cardiovascular and renal effects of synthetic β-human calcitonin gene-related peptide (β-hCGRP) were examined in conscious normotensive and one-kidney one-clip (1K-1C) hypertensive dogs. β-hCGRP was infused intravenously at 10 and 50 ng/kg/min for 75-min periods each. Mean arterial pressure did not change significantly (p>0.05) in either group during low dose infusion of β-hCGRP, but infusion of β-hCGRP at 50 ng/kg/min produced a fall in mean arterial pressure from 140±4 to 116±6 mmHg (p<0.05) in the hypertensive dogs (n=4) and from 100±4 to 78±3 mmHg (p<0.05) in the normotensive dogs (n=4). Heart rates increased significantly during infusion of β-hCGRP in both groups. Also, renal sodium and potassium excretion decreased (p<0.05) in the two groups at both the low and high doses of β-hCGRP. Creatinine clearance was unchanged in normal dogs and decreased (p<0.05) in 1K-1C hypertensive dogs at the high rate of β-hCGRP infusion. The clearance of p-aminohippurate increased approximately 20{\%} (p<0.05) in both groups with the low dose infusion of β-hCGRP but further increases were elecited only in the normotensive dogs in response to the elevation in the β-hCGRP infusion rate. Plasma renin and aldosterone levels increased (p<0.05) above control levels during the maximum hypotensive response to β-hCGRP infusion in both groups. These data indicate that β-hCGRP is a potent blood pressure lowering agent with important effects on renal hemodynamics and excretory function in both normotensive and 1K-1C hypertensive dogs during sustained intravenous infusions.",
keywords = "Calcitonin gene-related peptide, Mean arterial pressure, Renal sodium excretion, Renovascular hypertension",
author = "Verburg, {Kenneth M.} and Freeman, {Ronald H.} and Daniel Villarreal and Brands, {Michael W.}",
year = "1989",
month = "1",
day = "1",
doi = "10.1016/0196-9781(89)90157-5",
language = "English (US)",
volume = "10",
pages = "663--669",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Cardiovascular and renal effects of calcitonin gene-related peptide in hypertensive dogs

AU - Verburg, Kenneth M.

AU - Freeman, Ronald H.

AU - Villarreal, Daniel

AU - Brands, Michael W.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - The systemic cardiovascular and renal effects of synthetic β-human calcitonin gene-related peptide (β-hCGRP) were examined in conscious normotensive and one-kidney one-clip (1K-1C) hypertensive dogs. β-hCGRP was infused intravenously at 10 and 50 ng/kg/min for 75-min periods each. Mean arterial pressure did not change significantly (p>0.05) in either group during low dose infusion of β-hCGRP, but infusion of β-hCGRP at 50 ng/kg/min produced a fall in mean arterial pressure from 140±4 to 116±6 mmHg (p<0.05) in the hypertensive dogs (n=4) and from 100±4 to 78±3 mmHg (p<0.05) in the normotensive dogs (n=4). Heart rates increased significantly during infusion of β-hCGRP in both groups. Also, renal sodium and potassium excretion decreased (p<0.05) in the two groups at both the low and high doses of β-hCGRP. Creatinine clearance was unchanged in normal dogs and decreased (p<0.05) in 1K-1C hypertensive dogs at the high rate of β-hCGRP infusion. The clearance of p-aminohippurate increased approximately 20% (p<0.05) in both groups with the low dose infusion of β-hCGRP but further increases were elecited only in the normotensive dogs in response to the elevation in the β-hCGRP infusion rate. Plasma renin and aldosterone levels increased (p<0.05) above control levels during the maximum hypotensive response to β-hCGRP infusion in both groups. These data indicate that β-hCGRP is a potent blood pressure lowering agent with important effects on renal hemodynamics and excretory function in both normotensive and 1K-1C hypertensive dogs during sustained intravenous infusions.

AB - The systemic cardiovascular and renal effects of synthetic β-human calcitonin gene-related peptide (β-hCGRP) were examined in conscious normotensive and one-kidney one-clip (1K-1C) hypertensive dogs. β-hCGRP was infused intravenously at 10 and 50 ng/kg/min for 75-min periods each. Mean arterial pressure did not change significantly (p>0.05) in either group during low dose infusion of β-hCGRP, but infusion of β-hCGRP at 50 ng/kg/min produced a fall in mean arterial pressure from 140±4 to 116±6 mmHg (p<0.05) in the hypertensive dogs (n=4) and from 100±4 to 78±3 mmHg (p<0.05) in the normotensive dogs (n=4). Heart rates increased significantly during infusion of β-hCGRP in both groups. Also, renal sodium and potassium excretion decreased (p<0.05) in the two groups at both the low and high doses of β-hCGRP. Creatinine clearance was unchanged in normal dogs and decreased (p<0.05) in 1K-1C hypertensive dogs at the high rate of β-hCGRP infusion. The clearance of p-aminohippurate increased approximately 20% (p<0.05) in both groups with the low dose infusion of β-hCGRP but further increases were elecited only in the normotensive dogs in response to the elevation in the β-hCGRP infusion rate. Plasma renin and aldosterone levels increased (p<0.05) above control levels during the maximum hypotensive response to β-hCGRP infusion in both groups. These data indicate that β-hCGRP is a potent blood pressure lowering agent with important effects on renal hemodynamics and excretory function in both normotensive and 1K-1C hypertensive dogs during sustained intravenous infusions.

KW - Calcitonin gene-related peptide

KW - Mean arterial pressure

KW - Renal sodium excretion

KW - Renovascular hypertension

UR - http://www.scopus.com/inward/record.url?scp=0024313272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024313272&partnerID=8YFLogxK

U2 - 10.1016/0196-9781(89)90157-5

DO - 10.1016/0196-9781(89)90157-5

M3 - Article

C2 - 2674914

AN - SCOPUS:0024313272

VL - 10

SP - 663

EP - 669

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 3

ER -